Several brokerages have updated their recommendations and price targets on shares of Delek US (NYSE: DK) in the last few weeks:
- 10/17/2024 – Delek US is now covered by analysts at Bank of America Co.. They set an “underperform” rating and a $15.00 price target on the stock.
- 10/10/2024 – Delek US had its price target lowered by analysts at Scotiabank from $25.00 to $22.00. They now have a “sector perform” rating on the stock.
- 10/9/2024 – Delek US had its price target lowered by analysts at Wells Fargo & Company from $21.00 to $18.00. They now have an “underweight” rating on the stock.
- 10/2/2024 – Delek US had its price target lowered by analysts at JPMorgan Chase & Co. from $26.00 to $19.00. They now have a “neutral” rating on the stock.
- 9/21/2024 – Delek US was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating.
- 9/20/2024 – Delek US had its price target lowered by analysts at Piper Sandler from $25.00 to $19.00. They now have a “neutral” rating on the stock.
- 9/16/2024 – Delek US had its price target lowered by analysts at Morgan Stanley from $24.00 to $22.00. They now have an “underweight” rating on the stock.
- 9/16/2024 – Delek US was upgraded by analysts at Mizuho from an “underperform” rating to a “neutral” rating. They now have a $26.00 price target on the stock, down previously from $28.00.
- 9/13/2024 – Delek US was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating.
- 9/10/2024 – Delek US was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating. They now have a $26.00 price target on the stock, up previously from $23.00.
- 9/5/2024 – Delek US was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating.
- 9/3/2024 – Delek US had its price target raised by analysts at Wells Fargo & Company from $20.00 to $21.00. They now have an “underweight” rating on the stock.
Delek US Stock Performance
Shares of DK stock traded down $0.28 on Monday, reaching $16.83. The stock had a trading volume of 1,172,402 shares, compared to its average volume of 1,060,452. The company has a debt-to-equity ratio of 2.50, a quick ratio of 0.58 and a current ratio of 0.98. Delek US Holdings, Inc. has a 1 year low of $16.50 and a 1 year high of $33.60. The stock has a market cap of $1.08 billion, a P/E ratio of -13.57 and a beta of 1.13. The company has a 50 day simple moving average of $19.70 and a 200 day simple moving average of $23.67.
Delek US (NYSE:DK – Get Free Report) last announced its earnings results on Tuesday, August 6th. The oil and gas company reported ($0.92) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.42) by $0.50. Delek US had a negative return on equity of 4.53% and a negative net margin of 0.69%. The business had revenue of $3.42 billion for the quarter, compared to analysts’ expectations of $3.31 billion. During the same period last year, the firm posted $1.00 earnings per share. The business’s revenue for the quarter was down 18.4% on a year-over-year basis. Equities research analysts expect that Delek US Holdings, Inc. will post -3.79 EPS for the current year.
Delek US Increases Dividend
Insiders Place Their Bets
In related news, CEO Avigal Soreq purchased 5,651 shares of the business’s stock in a transaction on Friday, August 9th. The stock was acquired at an average price of $20.42 per share, with a total value of $115,393.42. Following the completion of the acquisition, the chief executive officer now owns 188,881 shares of the company’s stock, valued at approximately $3,856,950.02. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 1.80% of the company’s stock.
Hedge Funds Weigh In On Delek US
Several large investors have recently added to or reduced their stakes in DK. Encompass Capital Advisors LLC purchased a new position in shares of Delek US during the 2nd quarter valued at $22,833,000. SIR Capital Management L.P. boosted its stake in shares of Delek US by 37.2% in the second quarter. SIR Capital Management L.P. now owns 876,133 shares of the oil and gas company’s stock worth $21,693,000 after acquiring an additional 237,734 shares during the period. Point72 Asset Management L.P. purchased a new stake in shares of Delek US during the second quarter worth about $19,806,000. Easterly Investment Partners LLC lifted its holdings in Delek US by 26.7% in the 2nd quarter. Easterly Investment Partners LLC now owns 457,536 shares of the oil and gas company’s stock worth $11,329,000 after purchasing an additional 96,531 shares in the last quarter. Finally, Cubist Systematic Strategies LLC boosted its stake in Delek US by 99.7% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 378,744 shares of the oil and gas company’s stock worth $9,378,000 after purchasing an additional 189,091 shares during the period. Hedge funds and other institutional investors own 97.01% of the company’s stock.
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
Read More
- Five stocks we like better than Delek US
- Ride Out The Recession With These Dividend KingsĀ
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- Stock Average Calculator
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- Dividend Capture Strategy: What You Need to Know
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Delek US Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delek US Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.